Comparison of short head-up tilt test with conventional protocol after omission of nonmedicated phase in children and young adults

Document Type : Original Article

Authors

Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Syncope is an important and common clinical condition, and the neurally mediated syncope is the most frequent type of syncope. Tilt testing is considered as a first-line diagnostic test.
Materials and Methods: We conducted the conventional and modified tilt test on 200 subjects in the age range of 5-20 years. In conventional protocol, the patient was tilted for up to 15 min without medication. If syncope did not develop, the patient received 0.1 mg/kg sublingual isosorbide dinitrate. Then, the patient was continued to be tilted for another 15 min. In modified tilt test, before starting the test, the patient received 0.1 mg/kg isosorbide dinitrate sublingually in supine position. Then, the table was tilted for a maximum of 25 min or until the test became positive.
Results: In conventional tilt test group 79.13% and in modified tilt test group 87.06% of subjects showed positive results. In conventional tilt test, the mean of response time was 17.67 ± 4.74 min. The mean of the total time of conventional tilt test was 49.81 ± 5.57 min. In modified tilt test, the mean of response time was 7.24 ± 4.83 min. The mean of the total time of modified tilt test was 35.09 ± 7.58 min. Furthermore, the means of both response and total times between two groups were significantly different (P < 0.001).
Conclusions: Our study showed that we can save about 15-20 min in total test time which may increase the cooperation and compliance of young patients and decrease their anxiety with this new protocol.

Keywords

1.
Mohamed H. Syncope: Evaluation and management. Libyan J Med 2008;3:156-9.  Back to cited text no. 1
    
2.
Martin K, Bates G, Whitehouse WP. Transient loss of consciousness and syncope in children and young people: What you need to know. Arch Dis Child Educ Pract Ed 2010;95:66-72.  Back to cited text no. 2
    
3.
The Vanderbilt Autonomic Dysfunction Center, Neurally Mediated Syncope; 2016. Available from: www.mc.vanderbilt.edu/root/vumc. php?site=adc&doc=4789. [Last accessed on 2016 Mar 09].  Back to cited text no. 3
    
4.
Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams′ Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adults. 7 th ed. Philadelphia: Lippincott Williams & Wilkins; 2008:269-73.  Back to cited text no. 4
    
5.
Sabri MR, Mahmodian T, Sadri H. Usefulness of the head-up tilt test in distinguishing neurally mediated syncope and epilepsy in children aged 5-20 years old. Pediatr Cardiol 2006;27:600-3.  Back to cited text no. 5
    
6.
Oribe E, Caro S, Perera R, Winters SL, Gomes JA, Kaufmann H. Syncope: The diagnostic value of head-up tilt testing. Pacing Clin Electrophysiol 1997;20(4 Pt 1):874-9.  Back to cited text no. 6
    
7.
Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, et al. Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncope. Europace 2001;3:253-60.  Back to cited text no. 7
    
8.
Sabri MR, Maghzian M. Isosorbide dinitrate is a safe provocative agent in head up tilt test in children and adolescents and increase positivity and decrease the duration of the test. J Isfahan Med Sch 2007;25:31-7.  Back to cited text no. 8
    
9.
Raviele A, Giada F, Brignole M, Menozzi C, Marangoni E, Manzillo GF, et al. Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope. Am J Cardiol 2000;85:1194-8.  Back to cited text no. 9
    
10.
Ramezan BK, Moshkani Farahani M, Bahrami Ahmadi A. The head-up tilt test in patients with unexplained syncope or presyncope. Iran Heart J 2012;13:16-21.  Back to cited text no. 10
    
11.
Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.  Back to cited text no. 11
    
12.
Shen WK, Jahangir A, Beinborn D, Lohse CM, Hodge DO, Rea RF, et al. Utility of a single-stage isoproterenol tilt table test in adults: A randomized comparison with passive head-up tilt. J Am Coll Cardiol 1999;33:985-90.  Back to cited text no. 12
    
13.
Aerts AJ, Dendale P. Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group. Pacing Clin Electrophysiol 2005;28:29-32.  Back to cited text no. 13
    
14.
Khan HF, Hameed MA, Khan UA. Short duration head-up tilt test: A comparison with conventional long protocol in patients of orthostatic intolerance. J Ayub Med Coll Abbottabad 2010;22:78-80.  Back to cited text no. 14
    
15.
Parry SW, Gray JC, Newton JL, Reeve P, O′Shea D, Kenny RA. ′Front-loaded′ head-up tilt table testing: Validation of a rapid first line nitrate-provoked tilt protocol for the diagnosis of vasovagal syncope. Age Ageing 2008;37:411-5.  Back to cited text no. 15
    
16.
Mansourati J, Blance JJ. Tilt test procedure: Angle, duration, positivity criteria. In: Blanc JJ, Benditt D, Sutton R, editors. From Neurally Mediated Syncope. Armonk, NY: Futura Publishing Co.; 1996. p. 7983.  Back to cited text no. 16